Michael Wise is the firm’s US Antitrust & Competition Practice Group Leader, resident in the Washington DC office.
His practice focuses on a full spectrum of antitrust issues, including merger clearance under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) and corresponding foreign regimes, regulatory investigations, and civil and criminal litigation matters. He has experience across a wide range of industries, including private equity and financial services, media, transportation, energy and manufacturing.
On transactional matters, Michael regularly advises on the full life cycle of a prospective deal, including strategic advice, negotiation of antitrust-related purchase agreement provisions, information exchange and clean team issues, regulatory filings, and government investigations. His focus is always to maximize certainty, both with respect to deal timelines and also with respect to the scope of antitrust risk.
In defending clients against allegations of anticompetitive behavior, Michael has successfully represented clients facing civil and criminal claims under the Sherman Act, as well as challenges under state antitrust and unfair competition statutes. He also provides comprehensive antitrust compliance counseling to minimize litigation risks.
Michael is also active in the American Bar Association (ABA) Antitrust Law section, where he has served as a mentor for young antitrust practitioners and held leadership positions on the Compliance and Ethics Committee and the editorial board for Antitrust Law Developments.
Co-author, “DOJ China Container Indictments Signal Global Cartel Risk,” Law360, July 1, 2026.
Co-author, “5 Ways In-House Counsel Can Stay Ahead of New HSR Rules,” Law360, June 2025.
Author, “Pace Of Early Terminations Suggests Greater M&A Scrutiny”, Law360, May 2025.
Co-author, “Trump's DOJ Antitrust Nominee Reveals Enforcement Focus,” Westlaw Today, February 2025.
Author, “2 Cases May Signal Where FTC Is Headed On Labor Issues,” Law360, January 2025.
Co-author, “FTC Report on AI Sector Illuminates Future Enforcement,” Law360, January 2025.
Co-author, “5 Antitrust Issues For In-House Counsel In 2025,” Law360, January 2025.
Moderator, “Beyond Section 8: Addressing Director Interlock Issues,” Antitrust On-Demand, ABA, February 2024.
Author, “Biden’s Pricing Strike Force Is Poorly Equipped for a Tough Task,” Bloomberg Law, March 2024.
Co-author, “Taking Stock of Antitrust Efforts Targeting Private Equity,” Wall Street Lawyer, November 2023.
Co-author, “Considerations For Private Equity After FTC Vet Clinic Deal,” Law360, July 2022 (subscription required).
Moderator, “Antitrust After 2020: Reversion to the Mean or Revolution?” webinar, October 2020.
Co-author, “Tronox, Cristal Merger Review Underscores Need for Reform,” Law360, September 2018.
Co-author, “US Merger Control in the High-technology Sector,” The Merger Control Review, 9th Edition, September 2018.
Panelist, “Hart-Scott-Rodino Act: Best Practices to Avoid Risks and Pitfalls,” The Knowledge Group, December 2017.
Contributor, “Antitrust Law,” Handbook on Antitrust in Technology Industries, ABA, November 2017.
Co-author, “US Merger Control in the High-technology Sector,” The Merger Control Review, 8th Edition, September 2017.
Speaker, “Reducing Costs in Multilingual Discovery,” International Legal Technology Association, April 2017.
Co-author, “US Merger Control in the High-technology Sector,” The Merger Control Review, 7th Edition, August 2016.